Abstract Neurons have highly specialized intracellular compartments that facilitate the development and activity of the nervous system. Ubiquitination is a post-translational modification that controls many aspects of neuronal function by regulating protein abundance. Disruption of this signaling pathway has been demonstrated in neurological disorders such as Parkinson's disease, Amyotrophic Lateral Sclerosis and Angleman Syndrome. Since many neurological disorders exhibit ubiquitinated protein aggregates, the loss of neuronal ubiquitin homeostasis may be an important contributor of disease. This review discusses the mechanisms utilized by neurons to control the free pool of ubiquitin necessary for normal nervous system development and function as well as new roles of protein ubiquitination in regulating the synaptic activity.
Introduction
While many of the processes that require ubiquitin are common to all cell types, ubiquitin also has distinct roles in highly specialized and structurally unique cells like neurons [1] . During neuronal development, both synapse formation [2] and synaptic pruning [3] are regulated by the ubiquitin proteasome system, as are excitatory [4, 5] and inhibitory [5] transmission in the mature brain. Although, the protein degradation is the most well-studied aspect of the ubiquitin proteasome system, protein ubiquitination is also responsible for regulating the cell signaling by controlling the endocytosis of plasma membrane receptors [1] . The complex morphology of neurons makes the regulation of ubiquitin levels more challenging than in morphologically simpler cell types [6] .
Ubiquitin, a highly conserved 76-amino acid protein, was originally described in 1975 in studies aimed at discovering hormones produced by the thymus [7] . It was later shown to be identical to ATP-dependent proteolysis factor 1 [8] , which was implicated in protein degradation by the pioneering work of Aaron Ciechanover, Avram Hershko, and Irwin Rose [9, 10] . Ubiquitin has since been identified in all the eukaryotic cells and, although it was first studied for its role in tagging proteins for degradation by the proteasome, it is now known to be involved in processes as varied as signal transduction, endocytosis, and DNA repair.
The levels of free ubiquitin in a cell are determined by the rates of ubiquitin synthesis, polyubiquitin chain formation, polyubiquitin chain disassembly, and ubiquitin degradation. We use to the term ''free'' ubiquitin to designate the unconjugated pool of ubiquitin, and ''conjugated'' to refer to ubiquitin that has been covalently attached to substrates of the ubiquitin proteasome system. In mouse brain, 60 % of the processed ubiquitin is found as a free monomer and 40 % is conjugated onto substrates [11] . Of the conjugated ubiquitin, approximately 90 % is found on mono-ubiquitinated substrates and 10 % is found on polyubiquitinated substrates. The high levels of free ubiquitin found in neurons may serve as a reservoir to allow for rapid responses to cell stimulation or stress. In this review, we will discuss the mechanisms utilized by the neurons to control the ubiquitin levels, the consequences of altering ubiquitin homeostasis, and novel roles for protein ubiquitination in regulating the synaptic activity.
De novo Ubiquitin Synthesis
Two classes of genes encode ubiquitin in the mammalian genome: the ribosomal fusion proteins Rsp27a and Uba52, which are constitutively expressed, and the poly-ubiquitin genes Ubb and Ubc, which are induced by various forms of cellular stress [12, 13] . Rsp27a and Uba52 each encode a single ubiquitin moiety fused to a small ribosomal protein, whereas Ubb and Ubc encode 3 and 9 tandem ubiquitin repeats, respectively. In all these cases, the generation of monomeric ubiquitin requires post-translational cleavage of fusion proteins by ubiquitin-specific proteases, notably Usp5 [14] .
Although, both Ubb and Ubc are transcribed at increased rates in response to cell stress [12, 13] , both ubiquitin polyproteins also appear to contribute to basal ubiquitin levels. For instance, in mice, Ubb accounts for more than 60 % of the total ubiquitin transcripts in the testes and nearly 40 % in the brain [15] . Although the redundancy in ubiquitin genes should, presumably, allow for an increase in transcription of the remaining genes to compensate for loss of Ubb, ubiquitin levels are significantly decreased in both the gonads and the hypothalamus of Ubb knockout mice [15] [16] [17] . Ubb knockout mice have a developmental arrest of spermatocytes and oocytes prior to the first meiotic division, hypogonadism, and late onset obesity due to hypothalamic dysfunction. Similarly, mouse embryonic fibroblasts that lack Ubc show a significant decrease in ubiquitin. Expression of Ubc appears to be especially important in liver development, as knockout of Ubc in mice is embryonically lethal due to the reduced proliferation of fetal liver cells [16, 18] .
Transport of Ubiquitin in Neurons
Following the de novo generation of ubiquitin in the cell body, ubiquitin is transported from the soma to distant locals like axons and dendrites. A single study in the literature indicates that the ubiquitin is trafficked via slow axonal transport down the rat optic nerve [6] . This transport proceeds at a rate of approximately 3 mm/day, indicating that the length of time required for newly generated ubiquitin to reach synaptic terminals is on the order of days, or even weeks, in some neurons. As ubiquitin is a component of the cellular response to heat shock and other stressors, the slow rate of transport may therefore make distal axons and dendrites particularly vulnerable to stress. For example, the accumulation of ubiquitin-positive deposits in axons and dendrites of the diseased neurons demonstrates that the protein degradation is compromised in these compartments. Sequestration of ubiquitin in these aggregates may contribute to a local depletion in free ubiquitin that can only be replenished by ubiquitin synthesized in the soma.
Conjugation of Ubiquitin to Target Proteins
Rates of ubiquitin conjugation and deconjugation can directly influence the steady-state levels of free ubiquitin. For example, the proteasome inhibition results in a shift in ubiquitin from the free pool to the conjugated pool. Ubiquitin is activated for conjugation by an E1 enzyme that harnesses ATP hydrolysis to adenlyate ubiquitin's C-terminal glycine [19] . This high-energy intermediate is subject to rapid nucleophilic attack by the E1 enzyme's active-site cysteine, forming a high-energy thioester bond. Activated ubiquitin is then passed to the active-site cysteine of an E2 enzyme, which interacts with the ubiquitincharged E1 enzyme with high affinity [20, 21] . Upon dissociation of the uncharged E1 activating enzyme [22] , the E2 enzyme interacts with an E3 enzyme that is associated with the protein to be ubiquitinated, resulting in an isopeptide bond between ubiquitin's C-terminal glycine, and the e-amino group in a substrate's lysine residue.
Conjugation of a single ubiquitin moiety to a protein, termed monoubiquitination, is an important signaling event in endocytosis and transcriptional regulation [23] . However, because ubiquitin itself contains seven lysines, ubiquitin chains can be formed by ligation of the C-terminal glycine residue to a lysine residue in another ubiquitin monomer [24] . The most well-characterized ubiquitin chain is the K48-linkage, which targets proteins to the proteasome for degradation [24] [25] [26] . K63-chains are involved in signal transduction, scaffolding [27] , and DNA repair [28] . Although, monoubiquitination has been shown, in vitro, to be sufficient for receptor endocytosis [29, 30] , many subsequent studies show that K63-linked chains lead to more efficient processing through the endosome-lysosome pathway. However, recent studies indicate that ubiquitin signaling is significantly more complicated than previously appreciated and, although these generalizations form a useful framework for introducing the biological consequences of various ubiquitin linkages, functional categorization of specific ubiquitination events is far from straightforward [31] .
Ubiquitin Deposition in Protein Aggregates
An increase in ubiquitin conjugates is associated with several neurodegenerative disorders [32] [33] [34] . In Parkinson's disease, focal accumulations of ubiquitinated a-synuclein can be found in Lewy-bodies. Ubiquitinated protein aggregates are also found in neurofibrillary tangles from postmortem brains of patients with Alzheimer's disease. While the role that these aggregates play in actually causing disease is controversial, the formation of these aggregates could result in ''trapping'' ubiquitin molecules, lowering the free ubiquitin pool, and decreasing ubiquitindependent proteolysis. Consistent with this idea, the mouse models of ubiquitin deficiency due to either loss of ubiquitin expression or increased ubiquitin turnover result in neurodegenerative disease [15-17, 35, 36] .
Post-Translational Stability of Ubiquitin in Neurons
An under-appreciated consequence of protein turnover at the proteasome is the destruction of ubiquitin. In vitro studies demonstrate that the ubiquitin can enter the proteasome either as free monomers or conjugated to substrates [37] . This finding indicates that, although the proteasome contains several deubiquitinating enzymes to facilitate ubiquitin recycling, there is a continual degradation of ubiquitin by the proteasome. Since the consequences of ubiquitin depletion can be dire, especially in neurons, the advantages of constitutive ubiquitin degradation by the proteasome are intriguing. Ubiquitin turnover could serve to eliminate the damaged ubiquitin molecules to maintain a functional pool of ubiquitin or allow for acute changes in ubiquitin levels to modulate ubiquitin-signaling events. The following section will address how the changes in deubiquitinating enzymes can alter the levels of ubiquitin in neurons and discuss how these changes in ubiquitin levels affect the synaptic development and function.
Sequestration of Ubiquitin Pools by UCHL1
Ubiquitin C-terminal hydrolase 1 (UCHL1) is a highly abundant protein in neurons and is thought to play an important role in ubiquitin homeostasis. Interest in the role of UCHL1 in the nervous system was sparked when a German family with Parkinson's disease was shown to have a missense mutation in Uchl1 that reduced its protease activity [38] . This finding implicated a possible connection between defective ubiquitin-dependent protein turnover and Parkinson's disease. Shortly after this study was published, the spontaneously occurring gracile axonal dystrophy (gad) mouse mutation was shown to be in the Uchl1 gene [39] . The gad mice display a late onset motor ataxia that correlates with the accumulation of ubiquitinated proteins and nerve terminal swellings [39] . A first indication of UCHL1's involvement in ubiquitin homeostasis was the finding that monomeric ubiquitin levels are significantly reduced in brain extracts from gad mice [35] . This decrease in monomeric ubiquitin levels was not associated with an up-regulation of Ubb or Ubc transcription. The lack of a ubiquitin stress response suggests that the loss of UCHL1 may result in compartment-specific destabilization of ubiquitin, and that the ubiquitin present in other compartments prevents an increase in Ubb and Ubc transcription. Since UCHL1 has a high affinity for ubiquitin, it has been suggested that UCHL1 may serve to sequester ubiquitin and prevent its degradation. Consistent with this idea, transgenic overexpression of UCHL1 results in increased levels of free ubiquitin [35] .
The postsynaptic compartment of a neuron is one region that is sensitive to loss of UCHL1. Rapid ubiquitindependent proteasomal protein turnover occurs in the postsynaptic compartment following synaptic activity, and this regulated protein degradation is critical to activitydependent strengthening and weakening of synaptic connections [40] . Genetic deletion of UCHL1 reduces longterm potentiation (a long-term increase in synaptic strength) [41] , and UCHL1 inhibition leads to an increase in the size of dendritic spines and a decrease in their density [42] , demonstrating the importance of UCHL1 in the postsynaptic compartment. Interestingly, these changes in spine morphology are reversed by ectopic expression of ubiquitin, arguing that a critical role of UCHL1 in the postsynapse is the maintenance of ubiquitin pools.
USP14 Prevents Proteasomal Degradation of Ubiquitin
Ubiquitin-specific protease 14 (USP14) is a deubiquitinating enzyme that dynamically associates with the proteasome to stabilize the ubiquitin levels [36, 43] . While unbound USP14 has little catalytic activity, the association of USP14 with the proteasome dramatically stimulates its ubiquitin hydrolase activity [36, 44] . By controlling the association of USP14 with the proteasome, the cell is therefore able to restrict USP14's deubiquitinating activity to substrates bound to the proteasome. In vitro studies have also shown that the loss of USP14 leads to enhanced turnover of ubiquitinated proteins by the proteasome [45] . These findings indicate that the USP14 is tightly regulated by the proteasome, and changes in the activity of USP14 can alter ubiquitin-dependent protein turnover by the proteasome.
The ataxia (ax J ) mice have been used as an animal model to investigate the in vivo effects of Usp14 deficiency on the neuronal function [46] . In the ax J mice, there is a 40 % loss of monomeric ubiquitin in all the tissues, which results in a ''ubiquitin-stress'' response that is measured by two-five-fold increases in Ubb and Ubc transcripts, indicating that USP14 plays an important role in stabilizing the ubiquitin pools (Fig. 1) . The greatest levels of ubiquitin loss are observed at synaptic terminals, demonstrating the importance of USP14 for ubiquitin stability at synapses [47] . These changes in free ubiquitin correlate with the accumulation of neurofilaments and nerve terminal swellings at the ax J neuromuscular junctions [47] . In addition to the structural changes, the ax J neuromuscular junctions are functionally compromised and exhibit giant mini-endplate potentials, reduced mini-endplate frequencies, reduced quantal content, and synaptic failures. These structural and functional deficits are corrected by neuronal-specific transgenic expression of Usp14 in the ax J mice, demonstrating that USP14 has a critical presynaptic function in neurons [48] . This function appears to be in maintaining ubiquitin stability, as transgenic expression of ubiquitin also corrected the synaptic transmission and structural deficits at the ax J neuromuscular junction [49] . Since no postsynaptic deficits have been observed in the ax J mice, USP14 may have a primary function at the presynaptic terminal. As the motor neuron terminals are located great distances from the site of ubiquitin synthesis, the local levels of ubiquitin may be highly dependent on USP14 to maintain the ubiquitin pools required by the ubiquitin proteasome system in the presynaptic compartment.
Ubiquitin Over-Expression Leads to Neurological Abnormalities
Although, studies have investigated how loss of ubiquitin can contribute to neurological disease, there have not been any reports on the effect of ubiquitin overexpression on the nervous system. Research on the yeast orthologue of USP14, Ubp6, indicated that the expression of a deubiquitinating enzyme can be tightly coupled to ubiquitin levels [50] . In mice, the ubiquitin depletion by loss of UCHL1 did not affect the neuronal expression of Usp14, and loss of Usp14, did not affect the levels of UchL1. Transgenic mice that overexpress ubiquitin have also been developed to determine the interplay of ubiquitin and USP14 in the mammalian nervous system [49] . Overexpression of ubiquitin two-three-fold in the nervous system did not alter the transcription of Usp14, showing that Usp14 expression is not controlled by ubiquitin levels in neurons (Fig. 2a, b) . Interestingly, increasing neuronal ubiquitin levels results in a significant increase in the levels of conjugated ubiquitin, indicating that the modulation of local ubiquitin levels can alter the landscape of ubiquitin protein conjugates and affects ubiquitin signaling. Consistent with a cellular attempt to maintain ubiquitin levels at a specific set point, expression of endogenous Ubb, and Ubc significantly decreased in the ubiquitin-overexpressing mice. In contrast, the transcript levels of Psmb1, Psmb2, Uch37, Uchl3 and Uchl1 did not appear to be altered in the brains of mice overexpressing ubiquitin. While ubiquitin overexpression did not have broad effects on ubiquitin proteasome system gene expression, transgenic mice that overexpressed the ubiquitin in neurons exhibited structural defects at the neuromuscular junction. These alterations included motor endplate swellings and decreased acetylcholine receptor arborization (Fig. 2b) . Surprisingly, the effects of ubiquitin overexpression on the morphology of the neuromuscular junction were very similar to those seen in ubiquitin-deficient Usp14 and Uchl1-deficient mice [47] . In addition to the structural deficits, the effect of increased ubiquitin expression can also be seen functionally at the neuromuscular junction. Increasing free ubiquitin levels in Usp14-deficient mice stimulates the mini-endplate frequency [49] . Given the far-reaching effects of ubiquitin in the cell, it is not clear if ubiquitin complementation corrects the initial mechanism of disease in ax J mice or simply masks it. However, these results suggest that the ubiquitination is coupled to synaptic transmission, and the regulation of ubiquitin levels must therefore be tightly controlled to allow for proper synapse development and function.
Roles for Ubiquitination at the Synapse
Since the original description of the ubiquitin proteasome system by Ciechanover, Hershko, and Rose in the late 1970's and early 1980's, numerous studies have linked ubiquitin to neuronal function [51] . While the contribution of protein ubiquitination in regulating synaptic protein abundance is well documented, there are hints in the Fig. 1 Effect of USP14 deficiency on ubiquitin gene transcription in neuronal and non-neuronal tissues. Quantitative PCR was performed on reverse-transcribed RNA isolated from the livers, kidneys, muscles, and brains of 6-week-old wild type (wt) and USP14-deficient ax J mice. Gapdh was used as control. Data are shown as mean ± SE, where n = 3 animals per genotype literature of additional roles for ubiquitin at the synapse, which may be independent of the protein degradation. For example, in isolated synaptic terminals, calcium entry mediates a rapid decrease in ubiquitin conjugates that is reversed within seconds [52] . As the reversibility of this phenomenon suggests, the decrease in ubiquitinated proteins is not blocked by proteasome inhibition and therefore does not appear to result from increased protein turnover. Instead, it may result from calcium-mediated stimulation of deubiquitinating enzymes or, as the authors suggest, inhibition of on-going protein ubiquitination. Although, the functional consequences of the decrease in ubiquitin conjugates are not known, it is certainly suggestive that the same stimulus that results in neurotransmitter release also decreases protein ubiquitination. It may be that ubiquitination, or lack thereof, transiently changes the protein activity, and these changes favor the release of neurotransmitter from the synapse.
A later study by Felix Schweizer's group further implicates acute ubiquitination events in neurotransmitter release [53] . These researchers demonstrate that proteasome inhibition in cultured hippocampal neurons increases the frequency of miniature synaptic events (mEPSCs and mIPSCs) without changing their amplitude or kinetics, which is suggestive of a presynaptic change in the probability of neurotransmitter release. The increase is independent of calcium, which implicates a change in activity of the presynaptic release machinery downstream of calcium entry. Surprisingly, an increase in ubiquitinated proteins is not observed during this same time frame, arguing against simple stabilization of the release machinery or other pro-release proteins. Inhibition of the E1 activating enzyme, which should affect the global level of ubiquitinated proteins in the opposite direction of proteasome inhibition, yields a similar increase in miniature postsynaptic potentials [53] . The authors hypothesize that the increased neurotransmitter release is derived from altering the state of a group of dynamically ubiquitinated proteins. This change can be brought about by reducing the protein ubiquitination or by inhibiting the proteasome, and sequestering ubiquitin on proteins bound for degradation. This study, together with the work of Chen et al. [52] , Fig. 2 Effects of ubiquitin overexpression on the mouse nervous system. a Representative immunoblot of ubiquitin levels from the brains of 6-week-old wild type mice (wt) and wild type mice containing the Thy1-ubiquitin transgene (wt ? TgUb). Gapdh was used as a loading control. b Quantitative PCR was performed on reversetranscribed RNA isolated from brains of 6-week-old wild type (wt) and wild type ubiquitin transgenic mice (wt ? TgUb). Data are shown as mean ± SE, where n = 3 animals per genotype. c Tibialis anterior muscles were prepared from 6-week-old wild type mice (wt) and wild type mice containing the Thy1-ubiquitin transgene (wt ? TgUb). Muscles were stained for neurofilaments (green) and acetylcholine receptors (red). suggests that the dynamic ubiquitination events may be important to presynaptic function, although the nature of these events and their substrates remain unknown.
Conclusions
Significant progress has been made in our understanding of how cells utilize ubiquitin to regulate the cellular pathways. The structure and function of the nervous system is dependent on regulated protein turnover by the proteasome, and changes in protein stability are thought to contribute to many chronic neurological diseases. While loss of ubiquitin modifying enzymes can disrupt neuronal function by altering the stability of individual proteins, loss of ubiquitin homeostasis is also a mechanism that can lead to neuronal dysfunction. Surprisingly, neurons seem to have a restricted range in which the ubiquitin levels must be maintained, as either a decrease or increase in ubiquitin expression can negatively impact the neuronal structure and function. The highly compartmentalized organization of neurons is likely an important contributor to their selective sensitivity to the changes in ubiquitin pools. Future study will likely uncover new targets of regulated protein degradation at synapses as well as identify additional roles for protein ubiquitination in regulating synaptic plasticity.
